ADCYAP1 and Parkinsonism: PACAP has shown in vivo protective effects in animal models of cerebral ischemia, Parkinson’s and Alzheimer’s disease, Huntington chorea, traumatic brain and spinal cord injury, and different retinal pathologies (Reglodi et al. 2017, 2018b).